Prosecution Insights
Last updated: October 25, 2026

Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

5 pending office actions • 3 art units • 3 examiners • 0 of 5 (0%) have an AI response strategy ready

Analysis

Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken has 1 pending office action currently active in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner and is being processed within 1 distinct art unit. This concentration suggests that the company's current innovation is being evaluated within a specific technical niche of the Biotechnology & Pharmaceuticals field, rather than across multiple disciplines.

The busiest examiner, ALAM, AYAAN A, is responsible for the 1 busiest examiner pending action. Since there is 1 distinct examiner involved, the company's current prosecution efforts are focused on the review of ALAM, AYAAN A. The alignment of 1 pending office action with 1 distinct art unit means that the examination will be governed by the specific standards of that single unit.

Practitioners should focus on the specific technical requirements of ALAM, AYAAN A to effectively resolve the 1 pending office action. The presence of 1 distinct examiner and 1 distinct art unit simplifies the management of the portfolio by providing a single point of contact. This focused approach allows for an efficient prosecution process for the 1 busiest examiner pending action currently on the docket.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (20%)
4
Medium (80%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other4 (80%)
Multi-statute (no §101)1 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KRISHNAN, GANAPATHY 3 52.7% +1.3%
FRONDA, CHRISTIAN L 1 82.5% +14.3%
JACOBSON, MICHELE LYNN 1 28.1% +33.9%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18247726 LOW METHOXYL, HIGHLY CALCIUM-REACTIVE PECTIN AND PROCESS FOR ITS PREPARATION FRONDA, CHRISTIAN L —

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18040414 PECTIN-CONTAINING PLANT FIBER COMPOSITION FOR PLANT-BASED ICE CREAM JACOBSON, MICHELE LYNN 15d

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18040414 PECTIN-CONTAINING PLANT FIBER COMPOSITION FOR PLANT-BASED ICE CREAM JACOBSON, MICHELE LYNN 15d
18247726 LOW METHOXYL, HIGHLY CALCIUM-REACTIVE PECTIN AND PROCESS FOR ITS PREPARATION FRONDA, CHRISTIAN L —

Top Art Units

Art UnitApps
1693 3
1652 1
1793 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18247726 LOW METHOXYL, HIGHLY CALCIUM-REACTIVE PECTIN AND PROCESS FOR ITS PREPARATION FRONDA, CHRISTIAN L 1652 §102§103DP Non-Final OA — Pending Apr 03, 2023
18040429 USE OF AN ACTIVATABLE, DE-ESTERIFIED, PECTIN-CONVERTED FRUIT FIBER FOR THE MANUFACTURING OF PRODUCTS KRISHNAN, GANAPATHY 1693 §103DP Non-Final OA — Pending Feb 03, 2023
18040421 USE OF AN ACTIVATABLE, DE-ESTERIFIED FRUIT FIBER FOR THE MANUFACTURING OF PRODUCTS KRISHNAN, GANAPATHY 1693 §103DP Non-Final OA 84d Pending Feb 02, 2023
18040414 PECTIN-CONTAINING PLANT FIBER COMPOSITION FOR PLANT-BASED ICE CREAM JACOBSON, MICHELE LYNN 1793 §102§103§112 Non-Final OA 15d Pending Feb 02, 2023
18009296 USE OF AN ACTIVATED PECTIN-CONTAINING CITRUS FIBER FOR PRODUCING PRODUCTS KRISHNAN, GANAPATHY 1693 §103DP Non-Final OA — Pending Dec 08, 2022

Managing Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken have?

Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken has 5 pending office actions as of October 2026, spread across 3 art units and 3 examiners.

Which USPTO examiner handles the most Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken applications?

Ganapathy Krishnan has the most, with 3 of Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken's pending office actions.

What technology area are Herbstreith & Fox GmbH & Co. KG Pektin-Fabriken's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month